Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Respiratory Syncytial Virus, Human”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT05045144
What this trial is testing

A Phase III Study to Assess the Lot-to-lot Consistency of GSK's Investigational RSV Maternal Vaccine and the Immune Response and Safety of RSV Maternal Vaccine When Given Alone or Co-administered With GSK's Influenza D-QIV Vaccine in Healthy Non-pregnant Women.

Who this might be right for
Respiratory Syncytial Virus Infections
GlaxoSmithKline 1,586
Testing effectiveness (Phase 2)Study completedNCT02707523
What this trial is testing

Prospective Pilot Clinical Trial of Azithromycin Treatment In Respiratory Syncytial Virus (RSV)- Induced Respiratory Failure In Children

Who this might be right for
Respiratory Syncytial Virus
University of Alabama at Birmingham 48
Not applicableStudy completedNCT01155193
What this trial is testing

Prospective Study for the Use of Palivizumab (Synagis®) in High-risk Children in Germany

Who this might be right for
Respiratory Syncytial Virus Infections
AbbVie (prior sponsor, Abbott) 30,804
Testing effectiveness (Phase 2)Study completedNCT05547087
What this trial is testing

A Dose Finding Study of VN-0200

Who this might be right for
Respiratory Syncytial Virus Infections
Daiichi Sankyo 342
Early research (Phase 1)Study completedNCT02296463
What this trial is testing

A Phase I Randomized, Observer-Blinded, Dose-Ranging Study in Healthy Subjects 24 to <72 Months of Age

Who this might be right for
Respiratory Synctial Virus
Novavax 32
Early research (Phase 1)Study completedNCT05281263
What this trial is testing

Phase 1 Study of BLB-201 Vaccine in Healthy Young and Older Adults

Who this might be right for
Respiratory Syncytial Virus Infections
Blue Lake Biotechnology Inc. 30
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07712380
What this trial is testing

A Study Exploring the Effect of Adjuvanted RZV or RSVPreF3 Vaccines on Coronary Plaque Progression in Adults >=50 Years of Age at Risk for Cardiovascular Events

Who this might be right for
Cardiovascular Disease
GlaxoSmithKline 450
Large-scale testing (Phase 3)Study completedNCT05437510
What this trial is testing

Study of a Single Intramuscular Dose of Nirsevimab in the Prevention of Hospitalizations Due to Respiratory Syncytial Virus (RSV) Infection in Healthy Term and Preterm Infants During the First Year of Life

Who this might be right for
RSV ImmunizationHealthy Volunteer
Sanofi Pasteur, a Sanofi Company 8,057
Large-scale testing (Phase 3)Study completedNCT02325791
What this trial is testing

Study to Evaluate the Efficacy and Safety of Suptavumab (REGN2222) for the Prevention of Medically Attended RSV (Respiratory Syncytial Virus) Infection in Preterm Infants

Who this might be right for
Respiratory Syncytial Virus Infections
Regeneron Pharmaceuticals 1,177
Early research (Phase 1)Study completedNCT04914520
What this trial is testing

Study of VN-0200 in Japanese Healthy Adults and Elderly Subjects

Who this might be right for
Respiratory Syncytial Virus Infections
Daiichi Sankyo Co., Ltd. 48
Early research (Phase 1)Study completedNCT04871724
What this trial is testing

Drug-Drug Interaction Study Between Fluconazole and EDP-938 in Healthy Subjects

Who this might be right for
RSV Infection
Enanta Pharmaceuticals, Inc 24
Large-scale testing (Phase 3)Study completedNCT06473519
What this trial is testing

Assess Safety, Tolerability and Immunogenicity of RSVpreF From Multidose Vials in Healthy Female Adults.

Who this might be right for
Respiratory Syncytial Virus (RSV)
Pfizer 453
Large-scale testing (Phase 3)Study completedNCT06890416
What this trial is testing

Evaluate the Safety and Immunogenicity of RSVpreF Coadministered With Herpes Zoster Vaccine in Adults

Who this might be right for
Respiratory Syncytial Virus (RSV)
Pfizer 526
Testing effectiveness (Phase 2)Study completedNCT04785612
What this trial is testing

Study of RSVpreF Vaccination and RSV Challenge in Healthy Adults

Who this might be right for
Respiratory Syncytial Virus Infections
Hvivo 70
Large-scale testing (Phase 3)Active Not RecruitingNCT06534892
What this trial is testing

An Extension and Crossover Vaccination Study on the Immune Response and Safety of a Vaccine Against Respiratory Syncytial Virus Given to Adults 60 Years of Age and Above Who Participated in RSV OA=ADJ-006 Study

Who this might be right for
Respiratory Syncytial Virus Infections
GlaxoSmithKline 10,212
Large-scale testing (Phase 3)Study completedNCT04424316
What this trial is testing

A Trial to Evaluate the Efficacy and Safety of RSVpreF in Infants Born to Women Vaccinated During Pregnancy.

Who this might be right for
Respiratory Tract Infection
Pfizer 14,727
Not applicableActive Not RecruitingNCT07122661
What this trial is testing

STudy of Real World vaccinE Effectiveness of maTernal RSVpreF vaccinatiON Against Respiratory Syncytial Virus (RSV) in Hospitalised Infants in Australia (STREETON)

Who this might be right for
Respiratory Syncytial Virus (RSV)Respiratory Syncytial VirusLower Respiratory Tract Disease+2 more
Pfizer 1
Testing effectiveness (Phase 2)Study completedNCT02094365
What this trial is testing

A Phase 2a Study to Evaluate ALS-008176 in the Virus Challenge Model

Who this might be right for
Respiratory Syncytial Virus Infections
Alios Biopharma Inc. 62
Not applicableStudy completedNCT05727202
What this trial is testing

Project STARFISH - PRJ0002679

Who this might be right for
SARS-CoV-2 InfectionInfluenza AInfluenza Type B+1 more
Thermo Fisher Scientific, Inc 1,909
Not applicableStudy completedNCT01297504
What this trial is testing

A One-Year Observation of Palivizumab in Infants at Risk for Respiratory Syncytial Virus Infection in Latin America

Who this might be right for
Respiratory Syncytial Virus Infection
AbbVie (prior sponsor, Abbott) 464
Next Page